ASCO 2025 Press Releases Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ...

There are other non-infectious IUC-related adverse effects that occur the longer an indwelling urinary catheter (IUC), particularly a transurethral IUC, is used for bladder drainage. They include ...

(UroToday.com) The 2025 AUA annual meeting featured a prostate cancer session and a presentation by Dr. Madison Krischak discussing access to prostate cancer clinical trials in the VA and whether ...

(UroToday.com) The American Urological Association's 2025 Annual Meeting, between April 26 – 29, 2025 in Las Vegas, Nevada, was host to the Plenary Session on Saturday 26 th of April. Drs. Lara ...

(UroToday.com) The 2025 AUA annual meeting featured a prostate cancer session and a presentation by Dr. Gal Wald discussing a multicenter comparison of retzius-sparing, hood, and standard techniques ...

(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to an advanced prostate cancer moderated poster session. Dr. Armando Stabile presented a ...

(UroToday.com) The 2025 AUA annual meeting featured an advanced prostate cancer session and a presentation by Dr. Christopher Pieczonka discussing data from the prespecified third interim analysis of ...

(UroToday.com) Sunday afternoon’s plenary session continued with an insightful talk by Dr. José Carlos Truzzi from the Federal University of Sao Paulo. Dr. Truzzi began the session with a brief ...